Literature DB >> 9840469

Self reported health status and magnetic resonance imaging findings in patients with low back pain.

W Hollingworth1, A K Dixon, C J Todd, M I Bell, N M Antoun, Q Arafat, S Girling, K R Karia, R J Laing.   

Abstract

The authors present a prospective study of quality of life (SF-36) and MRI findings in patients with low back pain (LBP). Disc herniation and nerve root compression contribute to LBP and poor quality of life. However, significant proportions of asymptomatic subjects have disc herniation and neural compromise. Little is known about the influence of disc abnormalities and neural compression on quality of life in symptomatic patients. The purpose of this study was to assess the relationship between the extent of disc abnormality, neural impingement and quality of life. A total of 317 consecutive patients with LBP referred for MRI completed an SF-36 health status questionnaire immediately before imaging and again 6 months later. Patients were grouped according to the most extensive disc abnormality and any neural compromise reported at MRI. The relationship between symptoms, radiological signs and SF-36 scores was assessed. Eighty percent (255/317) and 65% (205/317) of patients completed the initial and 6-month SF-36, respectively. Thirty-six percent of patients (115/317) had one or more herniated discs and 44% (140/317) had neural impingement. There was little relationship between the extent of disc abnormality and quality of life. Patients with radiological evidence of neural impingement reported better general health (P < 0.01). SF-36 scores improved at 6 months in four dimensions, but general health deteriorated (P < 0.01). Patients with neural impingement had improved pain scores at 6 months (P < 0.05). The study results showed that the pain and dysfunction caused by disc herniation and neural compromise are not sufficiently distinct from other causes of back pain to be distinguished by the SF-36. Whilst neural compromise may be the best radiological feature distinguishing patients who may benefit from intervention, it cannot predict quality of life deficits in the diffuse group of patients with LBP.

Entities:  

Mesh:

Year:  1998        PMID: 9840469      PMCID: PMC3611290          DOI: 10.1007/s005860050092

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  7 in total

1.  [Pilot study on pain response patterns in chronic low back pain. The influence of pain response patterns on quality of life, pain intensity and disability].

Authors:  S L Scholich; D Hallner; R H Wittenberg; A C Rusu; M I Hasenbring
Journal:  Schmerz       Date:  2011-04       Impact factor: 1.107

2.  Structural problems of the spine do not necessarily require intervention.

Authors:  John Hart
Journal:  J Can Chiropr Assoc       Date:  2007-03

Review 3.  Potential of magnetic resonance imaging findings to refine case definition for mechanical low back pain in epidemiological studies: a systematic review.

Authors:  Alison Endean; Keith T Palmer; David Coggon
Journal:  Spine (Phila Pa 1976)       Date:  2011-01-15       Impact factor: 3.468

4.  Relationship between low back pain, disability, MR imaging findings and health care provider.

Authors:  Estanislao Arana; Luis Martí-Bonmatí; María Vega; Daniel Bautista; Enrique Mollá; Salvador Costa; Rubén Montijano
Journal:  Skeletal Radiol       Date:  2006-04-07       Impact factor: 2.199

5.  Relationship between Northwick Park neck pain questionnaire and cervical spine MR imaging findings.

Authors:  Estanislao Arana; Luis Martí-Bonmatí; Ruben Montijano; Daniel Bautista; Enrique Molla; Salvador Costa
Journal:  Eur Spine J       Date:  2005-11-26       Impact factor: 3.134

6.  A rat model for chronic spinal nerve root compression.

Authors:  Feng Xue; Youzhen Wei; Yongqiang Chen; Yongjun Wang; Lingjun Gao
Journal:  Eur Spine J       Date:  2013-10-19       Impact factor: 3.134

7.  Cauda equina syndrome with normal MR imaging.

Authors:  Alasdair Rooney; Patrick F Statham; Jon Stone
Journal:  J Neurol       Date:  2009-02-25       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.